Large gap with delayed quotes
Analysis date: 27.06.2025
Global Evaluation
Neutral
Neutral
The stock is classified in the neutral zone since 24.06.2025.
Interest
Strong
Strong
Three stars since 13.06.2025.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 15.04.2025 at a price of 83.30.
Evaluation
Strongly overvalued
Strongly overvalued
Based on its growth potential and our own criteria, we believe the share price is currently overvalued.
MT Tech Trend
Positive
Positive
The forty day technical trend is positive since 02.05.2025.
4wk Rel Perf
1.38%
1.38%
The four-week dividend-adjusted overperformance versus SP500 is 1.38%.
Sensibility
Middle
Middle
The stock has been on the moderate-sensitivity level since 24.06.2025.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -0.20%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 2.69%.
Mkt Cap in $bn
30.18
30.18
With a market capitalization >$8bn, IRON MOUNTAIN is considered a large-cap stock.
G/PE Ratio
0.80
0.80
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential:
LT P/E
33.60
33.60
The estimated PE is for the year 2027.
LT Growth
23.88%
23.88%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
6
6
Over the last seven weeks, an average of 6 analysts provided earnings per share estimates.
Dividend Yield
3.14%
3.14%
The earnings forecasts are not sufficient to cover the twelve month estimated dividend.
Beta
91
91
For 1% of index variation, the stock varies on average by 0.91%.
Correlation
0.53
0.53
52.65% of stock movements are explained by index variations.
Value at Risk
21.65
21.65
The value at risk is estimated at USD 21.65. The risk is therefore 21.16%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
31.03.2004
31.03.2004